ALLMedicine™ Meningococcal Meningitis Center
Research & Reviews 327 results
https://doi.org/10.1080/21645515.2020.1857201
Human Vaccines & Immunotherapeutics; Xu Y, Li Y et. al.
Feb 10th, 2021 - Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines. The disease incidence was markedly reduced after meningo...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751252
Vaccine Sundaram ME, Wolfson J et. al.
Nov 23rd, 2020 - Vaccines to prevent meningococcal meningitis in the African meningitis belt include PsACWY, a polysaccharide-only vaccine; and PsA-TT, a polysaccharide-protein conjugate vaccine. Protein-energy undernutrition, a condition where children do not rec...
https://doi.org/10.1016/j.ijid.2020.11.134
International Journal of Infectious Diseases : IJID : Off... Tsutsumi K, Saito H et. al.
Nov 18th, 2020 - Herpes simplex virus 2 (HSV-2) is a well-known cause of neurological complications. This case study describes the first reported case of reactivated HSV-2 myelitis, which was induced by immunosuppression due to sepsis. During the treatment of meni...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703565
Proceedings of the National Academy of Sciences of the Un... Henriques P, Dello Iacono L et. al.
Nov 7th, 2020 - Meningococcal meningitis remains a substantial cause of mortality and morbidity worldwide. Until recently, countries in the African meningitis belt were susceptible to devastating outbreaks, largely attributed to serogroup A Neisseria meningitidis...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556464
PLoS Pathogens; Veggi D, Bianchi F et. al.
Oct 2nd, 2020 - Neisseria meningitidis serogroup B (MenB) is the leading cause of meningococcal meningitis and sepsis in industrialized countries, with the highest incidence in infants and adolescents. Two recombinant protein vaccines that protect against MenB ar...
Guidelines 3 results
https://www.ncbi.nlm.nih.gov/pubmed/22086889
The Journal of the American Osteopathic Association; Cyrus SS,
Dec 6th, 2011 - Meningococcal meningitis is a rare but often fatal disease. Throughout adolescence, the incidence of meningococcal meningitis increases, reaching a peak among individuals between the ages of 16 and 21 years. Vaccines are available to combat this d...
https://journals.lww.com/infectdis/Abstract/2010/07000/Differential_Diagnosis_of_Meningococcal_Meningitis.9.aspx
Infectious Diseases in Clinical Practice; Fretzayas,A.,et al
Jul 1st, 2010 - Background: The prompt diagnosis of meningitis is essential for a good outcome. Aim: This study was designed to differentiate children with meningococcal meningitis, aseptic meningitis, and no meningitis. Patients and Methods: A total of 150 chi...
https://www.menquadfi.com/
MenQuadfi is a vaccine indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidisserogroups A, C, W, and Y. MenQuadfi is approved for use in individuals 2 years of age and older. MenQuad...
Drugs 3 results see all →
Clinicaltrials.gov 333 results
https://doi.org/10.1080/21645515.2020.1857201
Human Vaccines & Immunotherapeutics; Xu Y, Li Y et. al.
Feb 10th, 2021 - Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines. The disease incidence was markedly reduced after meningo...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751252
Vaccine Sundaram ME, Wolfson J et. al.
Nov 23rd, 2020 - Vaccines to prevent meningococcal meningitis in the African meningitis belt include PsACWY, a polysaccharide-only vaccine; and PsA-TT, a polysaccharide-protein conjugate vaccine. Protein-energy undernutrition, a condition where children do not rec...
https://doi.org/10.1016/j.ijid.2020.11.134
International Journal of Infectious Diseases : IJID : Off... Tsutsumi K, Saito H et. al.
Nov 18th, 2020 - Herpes simplex virus 2 (HSV-2) is a well-known cause of neurological complications. This case study describes the first reported case of reactivated HSV-2 myelitis, which was induced by immunosuppression due to sepsis. During the treatment of meni...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703565
Proceedings of the National Academy of Sciences of the Un... Henriques P, Dello Iacono L et. al.
Nov 7th, 2020 - Meningococcal meningitis remains a substantial cause of mortality and morbidity worldwide. Until recently, countries in the African meningitis belt were susceptible to devastating outbreaks, largely attributed to serogroup A Neisseria meningitidis...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556464
PLoS Pathogens; Veggi D, Bianchi F et. al.
Oct 2nd, 2020 - Neisseria meningitidis serogroup B (MenB) is the leading cause of meningococcal meningitis and sepsis in industrialized countries, with the highest incidence in infants and adolescents. Two recombinant protein vaccines that protect against MenB ar...
News 3 results
https://www.medscape.com/viewarticle/807225
Jul 7th, 2013 - Reasons for Not Vaccinating Adolescents: National Immunization Survey of Teens, 2008-2010 Darden PM, Thompson DM, Roberts JR, et al Pediatrics. 2013;131:645-651 Vaccinating Teens Healthy People 2020 goals for adolescent immunization rates are 90% ...
https://journals.lww.com/infectdis/Abstract/2010/07000/Differential_Diagnosis_of_Meningococcal_Meningitis.9.aspx
Infectious Diseases in Clinical Practice; Fretzayas,A.,et al
Jul 1st, 2010 - Background: The prompt diagnosis of meningitis is essential for a good outcome. Aim: This study was designed to differentiate children with meningococcal meningitis, aseptic meningitis, and no meningitis. Patients and Methods: A total of 150 chi...
https://www.menquadfi.com/
MenQuadfi is a vaccine indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidisserogroups A, C, W, and Y. MenQuadfi is approved for use in individuals 2 years of age and older. MenQuad...